Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1007691 on May 29, 2008

Published online before print May 29, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1007691v1
84/3/835    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lee, M.-C.
Right arrow Articles by Tsao, P.-N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, M.-C.
Right arrow Articles by Tsao, P.-N.
(Journal of Leukocyte Biology. 2008;84:835-841.)
© 2008 by Society for Leukocyte Biology

Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages

Ming-Cheng Lee*, Shu-Chen Wei{dagger}, Jyy-Jih Tsai-Wu{ddagger}, C. H. Herbert Wu* and Po-Nien Tsao§,1

§ Departments of Pediatrics,
{dagger} Internal Medicine, and
{ddagger} Medical Research, National Taiwan University Hospital, and
* Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

1 Correspondence: Department of Pediatrics, National Taiwan University Hospital, Taipei 100, Taiwan. E-mail: tsaopn{at}ntu.edu.tw

In vitro activation of macrophages by LPS induces rapid release of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 receptor (sFlt-1), which are thought to be the effectors to cause sepsis. However, the signal pathway that controls the VEGF and sFlt-1 expressions in LPS-activated macrophages remains unclear. In this study, we demonstrated that phosphorylation of protein kinase C (PKC){delta} played a key role in the VEGF and sFlt-1 signaling pathway of LPS-activated macrophages. PKC is a family of serine-threonine kinases, which are classified into three major groups based on homology and cofactor requirements: conventional PKCs, novel PKCs, and atypical PKCs. In the murine RAW264.7 cells, as well as in primary human monocytes/macrophages, pretreatment with a general PKC inhibitor GF109203X or with a novel PKC{delta} inhibitor rottlerin or overexpression of a kinase-inactive form of PKC{delta} (K376R) eliminated LPS-induced sFlt-1 expression and augmented LPS-induced VEGF expression at the protein and the transcription levels. In contrast, Gö6976, an inhibitor for the conventional PKCs, or myristoylated PKC{zeta} pseudosubstrate peptide, an inhibitor for the atypical PKCs, failed to exert the same effects. These data suggest that PKC{delta} signaling is involved in LPS-induced sFlt-1 expression and serves as a negative mediator in LPS-induced VEGF expression in macrophages. A novel strategy controlling the LPS-induced PKC pathways, especially the PKC{delta} isoform, may be developed based on this study.

Key Words: sepsis • inflammation • vascular endothelial growth factor







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Leukocyte Biology.